tradingkey.logo

Imunon Sharpens Focus On Its Promising Pivotal Phase 3 Ovarian Cancer Study

ReutersFeb 5, 2026 1:28 PM

- Imunon Inc IMNN.O:

  • IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY

  • IMUNON INC - STRATEGIC RESTRUCTURING TO CUT NON-ESSENTIAL EXPENSES

  • IMUNON INC: PHASE 3 STUDY ENROLLMENT REMAINS AHEAD OF SCHEDULE AND ADVANCES COMPANY TOWARD FUTURE BLA FILING

  • IMUNON INC: ANNOUNCES STRATEGIC REORGANIZATION THAT WILL ELIMINATE HEADCOUNT NOT ESSENTIAL TO PHASE 3 TRIAL

  • IMUNON INC - KHURSHEED ANWER TO RETIRE AS EVP AND CSO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI